Peripheral Nerve Society - 2023 Annual Meeting

17 - 20 June 2023

Abstract Submission Rules & Regulations


Important Dates

Abstract Submission Deadline | Thursday, 12 January 2023 at 23.59 EST (US/Canada)

Abstract Changes Deadline | Thursday, 12 January 2023 at 23.59 EST (US/Canada). Changes must be made by logging into the portal. Changes after this date are not allowed.

Abstract Review | February 2023

Notification of Acceptance/Rejection | Friday, 3 March 2023

Late-Breaking Submission Opening | Wednesday, 26 April 2023

Abstract Presentation Selection Notification (Platform, Oral Poster, Poster) | Monday, 8 May 2023

Late-Breaking Submission Deadline | Wednesday, 10 May 2023 at 23.59 EDT (US/Canada)

Notification of Late-Breaking Acceptance/Rejection | Thursday, 18 May 2023

Presenting Author Registration Deadline | Friday, 9 June 2023

Lift of Abstract/Press Embargo | Friday, 9 June 2023 at 16.00 EDT (US/Canada)

PNS 2023 Annual Meeting | 17-20 June 2023

Important Information

All accepted abstracts will be included in the Annual Meeting mobile app and online abstract supplement. Accepted abstracts will be published in the Journal of the Peripheral Nervous System (JPNS) as submitted.

  • Abstracts previously presented at a national/international meeting may be submitted to the PNS. Please cite the meeting, location, and date of the previous presentation. Abstracts cannot be previously published.
  • The word limit for all abstracts is 300 words, NOT including the title and authors.
  • Presenting authors of accepted abstracts will be required to register for the meeting by 9 June 2023. Registration opens in early 2023.
  • There can be one presenter per accepted abstract, presenting on its behalf.
  • All presenting authors are expected to stand by their poster(s) for the full duration of their designated standby time.  There will be no option to present an e-poster at the 2023 Annual Meeting.
  • Abstracts may not be submitted by mail or email.
  • All accepted abstracts will be eligible for a poster presentation. Abstracts with the top scores will be invited for oral platform presentations in one of the sessions at the 2023 PNS Annual Meeting and will not be presented in poster form. Abstracts selected for oral poster presentations will still need to be presented in poster form.

Preparation of Your Abstract

  • No identifying features such as names of hospitals, medical schools, clinics, or cities may be listed in the title or text of the abstract. Do not include the names of any of the authors.  The names of authors and their affiliations (institutions) will be submitted online during the process.
  • Tables, graphs, and images are not permitted.
  • Avoid trade names whenever possible.
  • The title cannot be longer than (15) words but should clearly indicate the nature of the study. Capitalize the first letter of each word within the title.  Avoid abbreviations whenever possible.
  • All abstracts should be submitted in US English.
  • Abstracts should state briefly and clearly the purpose (within the introduction), methods, results, and conclusions of the work. There is a strict 300-word limit (title and authors not included).
      • Clearly state the purpose of the abstract.
      • Describe your selection of observations or experimental subjects.
      • Present your results in a logical sequence.
      • Emphasize new and important aspects of the study and conclusions drawn from them.

Changes to Your Abstract

Should you wish to correct an abstract already submitted and before the abstract submission deadline of 12 January 2023, please log in to the abstract submission portal and update your abstract. After the final submission deadline (12 January 2023), submitters can no longer modify or correct the abstract’s content, and the abstract will be published exactly as submitted.

Withdrawing an Abstract from the 2023 PNS Annual Meeting

The PNS expects that all accepted abstracts will, under all usual circumstances, be presented in person at the meeting in Copenhagen.  If the presenting author cannot present an abstract in person, you may add a substitute presenter. See “Substitute Presenters” on this page for details on how to do so.  Failure to present an accepted abstract may cause the author(s) to be ineligible for abstract submission at next year’s Annual Meeting.  To request the withdrawal of an abstract, please submit an Abstract Withdrawal Request. Withdrawals will only be accepted via this form; emailed requests will not be accepted.

The following information will be needed to complete your online abstract withdrawal request:

  • Abstract ID
  • Presenting author’s first and last name
  • Email address
  • Abstract title
  • Reason for withdrawal

Withdrawn abstracts will not be published in the Journal of the Peripheral Nervous System (JPNS).

Selection of Abstracts

The PNS Scientific Program Committee completes the abstract review process. As peers, they carefully review each abstract for content/consideration. The Editor-in-Chief of the JPNS is part of this peer review process and reviews the submission for publication.

Publication Information

Accepted abstracts will be published as a compilation in an abstract supplement of our Journal, the Journal of the Peripheral Nervous System (JPNS), under copyright by the Peripheral Nerve Society. The Society does not copyright individual abstracts, and you are free to publish or present your work elsewhere.

Abstract Prize Criteria

For ALL abstract prizes:

The abstract presenter must be a current Junior Member of PNS (dues paid) when the abstract is submitted. Please click here for more information on PNS membership.

The recipient is required to attend and present at the 2023 Annual Meeting.

Arthur K. Asbury Prize: The abstract must pertain to GBS/CIDP/Inflammatory.

Richard and Mary Bunge Prize: The abstract must pertain to nerve biology.

Peter J. Dyck Prize: The abstract must pertain to diabetes.

J.W. Griffin Prize: The abstract must pertain to regeneration.

Anita Harding Prize: The presenting author must be female.

Jonathan Pembroke Prize: The presenting author must be from Australia, New Zealand, or South Asia.

P.K. Thomas Prize: The abstract must pertain to inherited neuropathies.

Richard A.C. Hughes Prize: The abstract must pertain to clinical studies.

In evaluating each presentation, the prize committee will consider the quality of the presentation, groundbreaking/innovative results, and the quality of the presenter.

Request for Approval of Substitute Presenter

Substitute presenters must be approved in advance. The request for approval of a substitute presenter must be submitted by the First Author at least 48 hours before the scheduled abstract presentation.

Other notes:

Substitute presenters must be coauthor listed on the abstract, be qualified to discuss all aspects of the abstract during its presentation and pay the registration fee to attend the Annual Meeting.
Email requests will not be accepted.

A coauthor or colleague who is not preapproved via the Substitute Presenter Approval Request Form will not be allowed to present the abstract on behalf of the First Author.

The Substitute Presenter Approval Form is available here.

Late-Breaking Abstracts

Late-breaking abstract submission will be open from 26 April – 10 May 2023. Limited opportunities are available. Late-breaking abstracts must be novel or new. No abstracts that have been published are permitted (in-press is acceptable). Notification of acceptance will be sent on or by 18 May 2023.


Connect with PNS Executive Office Staff at with specific questions regarding the Annual Meeting.

PNS Executive Office:
1935 County Road B2 W · Suite 165 | Roseville, MN 55113 USA | +1.952.545.6284 | Management services provided by Global Management Partners. As a result of General Data Protection Regulation (GDPR), our Privacy Policy and Terms of Service have been updated to better explain our relationship with you. If you wish to opt in/out of receiving PNS communication, please update your Member Profile. 2022 Peripheral Nerve Society. All Rights Reserved.
Site by The Lone Designer | Privacy Policy | Terms of Service | Cookie Policy
Facebook Twitter